Febrile neutropenia is a common complication in cancer patients and
has been studied for more than 30 years. This is a field of cancer
in which much progress in supportive care has been made,
significantly reducing the morbidity and mortality from infections.
Tremendous numbers of patients have already benefited from specific
antineoplastic therapy and an even greater number could benefit
from the prevention of infection or from the allevation of symptoms
as a result of effective prophylaxis or adequate therapeutic
strategies. This book evaluates the achievements in the past and
identifies the major existing problems. It gives an overview of
therapeutic possibilities and presents new concepts and strategies
for making further progress.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!